EPA guidance on the early intervention in clinical high risk states of psychoses - Schmidt, S.J.; Schultze-Lutter, F.; Schimmelmann, B.G.; Maric, N.P.; Salokangas, R.K.R.; Riecher-Rössler, A.; van der Gaag, M.; Meneghelli, A.; Nordentoft, M.; Marshall, M.; Morrison, A.; Raballo, A.; et al. (European psychiatry, 2015)
Keywords: Adolescent; Adolescents; Adult; Antipsychotic Agents - therapeutic use; Antipsychotics; Cognitive-behavioral therapy; Early Diagnosis; Early intervention in Europe; Early Medical Intervention - statistics & numerical data; Humans; Internal Medicine; Male; Meta-analysis; Mood Disorders - diagnosis; Mood Disorders - therapy; Neuroprotective; Practice Guidelines as Topic; Prevention; Psychiatric Status Rating Scales; Psychiatry; Psychosis; Psychotic Disorders - diagnosis; Psychotic Disorders - therapy; Risk; Risk Factors; Schizophrenia - diagnosis; Schizophrenia - therapy; Treatment Outcome; Youth; Prevention; Psychosis; Antipsychotics; Neuroprotective; Early intervention in Europe; Risk; Youth; Cognitive-behavioral therapy; Adolescents; Meta-analysis